Parkinson's Disease; Studies from Jamia Hamdard University Add New Findings in the Area of Parkinson's Disease

Press/Media: Article/Feature

Period9 Apr 2011

Media coverage


Media coverage

  • TitleParkinson's Disease; Studies from Jamia Hamdard University Add New Findings in the Area of Parkinson's Disease
    Degree of recognitionInternational
    Media typePrint
    Country/TerritoryUnited States of America
    Description2011 APR 9 - ( -- Researchers detail in 'New non-oral drug delivery systems for Parkinson's disease treatment,' new data in Parkinson's disease. According to recent research from New Delhi, India, "Parkinson's disease (PD) remains the only neurodegenerative disorder for which there are highly effective symptomatic therapies, but still unmet needs regarding its long-term management. Levodopa (LD) remains the most effective treatment; however, chronic use is associated with potentially disabling motor complications." "AREAS COVERED: This review highlights a variety of new non-oral drug delivery strategies for non-invasive and invasive routes of drug administration for the treatment of PD. It also includes current and future trends of liposomes, solid lipid nanoparticles and biocompatible microparticles as new non-oral drug delivery systems. EXPERT OPINION: The long-term complications and limitations of LD treatment might be improved by changing therapy from the present pulsatile stimulation to a more constant stimulation of central dopamine receptors," wrote S. Md and colleagues, Jamia Hamdard University. The researchers concluded: "Stimulation of these receptors may be possible with a new non-oral drug delivery system, with the aim of achieving long-lasting and less fluctuating drug levels, minimization of peak levels and thereby reduction of side effects." Md and colleagues published their study in Expert Opinion On Drug Delivery (New non-oral drug delivery systems for Parkinson's disease treatment. Expert Opinion On Drug Delivery, 2011;8(3):359-74). For additional information, contact S. Md, Dept. of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India.. Keywords: City:New Delhi, Country:India, Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, Drug Delivery Systems, Drug Therapy, Movement Disorders, Neurodegenerative Diseases, Parkinson's Disease, Parkinsonian Disorders. This article was prepared by Obesity, Fitness & Wellness Week editors from staff and other reports. Copyright 2011, Obesity, Fitness & Wellness Week via
    Producer/AuthorObesity, Fitness & Wellness Week, NewsRx
    PersonsShadab Haque